Los puntos clave no están disponibles para este artículo en este momento.
The PCCRC-3y rate was 7.9% in Hong Kong, with a high proportion (> 80%) of distal cancers and a higher cancer-specific mortality compared with detected CRC.
Cheung et al. (Mon,) studied this question.